1. Home
  2. FIEE vs CTSO Comparison

FIEE vs CTSO Comparison

Compare FIEE & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FiEE Inc

FIEE

FiEE Inc

N/A

Current Price

$6.50

Market Cap

45.6M

Sector

Utilities

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.45

Market Cap

39.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIEE
CTSO
Founded
1977
1997
Country
Hong Kong
United States
Employees
43
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.6M
39.5M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
FIEE
CTSO
Price
$6.50
$0.45
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
7.1K
77.1K
Earning Date
05-14-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$10.34
Revenue Next Year
N/A
$22.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$1.50
$0.44
52 Week High
$7.95
$1.39

Technical Indicators

Market Signals
Indicator
FIEE
CTSO
Relative Strength Index (RSI) 36.91 28.17
Support Level $5.70 N/A
Resistance Level $7.28 $0.74
Average True Range (ATR) 0.33 0.04
MACD -0.06 -0.01
Stochastic Oscillator 18.31 8.67

Price Performance

Historical Comparison
FIEE
CTSO

About FIEE FiEE Inc

FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: